Join the Canada Leads Program on February 10th from 11 am to 12 pm for an engaging webinar exploring how UHN accelerates discovery and translates research into meaningful health innovation that improves patient care, outcomes, and health systems locally and globally.
The session will share success stories, lessons learned and candid insights into the opportunities and challenges of translating research into practice, including:
- Insights from Dr. Brad Wouters, Executive Vice President, Science and Research at UHN
- A moderated panel discussion with Dr. Andrea Furlan, Senior Scientist, KITE; Lead, Canadian Opiod Guideline; Chair, ECHO Chronic Pain and Opiod Stewardship and Dr. Scott Bratman, Senior Scientist, Princess Margaret Cancer Centre; Co-Founder and Chief Innovation Officer, Adela
This is the first session of a new Canada Leads engagement series on “Translating Research into Health Innovation and Economic Impact”. All are welcome to attend. Registration required. The session will be recorded and the recording sent to registrants.